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 Determining which patients with NICSMR
will beneﬁt from MS is a clinical dilemma.
 LV torsion (which is a shear strain, not
volume strain such as ejection fraction
and originates in LV myocardial
architectures) may reveal the myopathic
conditions and reﬂect intra-LV electrical
conduction.
 The LV torsional proﬁle predicted post-
MS outcomes in NICSMR patients with a
narrow QRS but not in those with a wide
QRS.
 The ﬁndings may help to resolve the
clinical dilemma and identify appropriate
candidates for mitral surgery (and other
resources) in patients with NICSMR.Center, Kanagawa, Japan; and the
hors have reported that they have
l 26, 2016.
ABBR EV I A T I ON S
AND ACRONYMS
CRT = cardiac
resynchronization therapy
EDV = end-diastolic volum
EF = ejection fraction
ESD = end-systolic dimens
GDMT = guideline-directed
medical therapy
LBBB = left bundle branch
block
LV = left ventricle/ventricu
NICSMR = nonischemic chr
secondary mitral regurgita
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194SUMMARYe
ion
lar
oni
tionThe selection of appropriate candidates for mitral surgery among symptomatic patients with nonischemic, chronic,
secondary severe mitral regurgitation (NICSMR) remains a clinical challenge. We studied 50 consecutive symptomatic
NICSMR patients for a median follow-up of 2.5 years after mitral surgery and concluded that the pre-operative
2-dimensional speckle tracking echocardiography-derived left ventricular torsional proﬁle and QRS width/
cardiac resynchronization therapy are potentially important prognostic indicators for post-surgery survival and
reverse remodeling. (J Am Coll Cardiol Basic Trans Science 2016;1:193–202) ©2016TheAuthors. Publishedby Elsevier on
behalf of the American College of Cardiology Foundation. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).SEE PAGE 203I n 2008, U.S. guidelines (1) stated, “Determiningthe surgical candidacy of the symptomaticpatient with mitral regurgitation (MR) and far-
advanced left ventricular (LV) dysfunction is a com-
mon clinical dilemma.” Even today, as stated in the
current U.S. guidelines published in 2014 (2), mitral
surgery for severely symptomatic patients with non-
ischemic, chronic, severe secondary mitral regurgita-
tion (NICSMR) is a Class IIb recommendation with
Level of Evidence (LOE): B. Because the primary cause
of this condition is cardiomyopathy, “restoration of
mitral valve competence is not by itself curative;
thus, the best therapy for chronic secondary MR is
much less clear than it is for chronic primary MR”
(2). The guidelines additionally stated, “Prognosis is
poor for both ischemic and nonischemic MR, but
ischemic MR lends itself to the possibility of revascu-
larization and potential improvement in LV function
if CAD has led to large areas of hibernating viable
myocardium” (2). This statement suggests that the
prognosis of NICSMR after mitral surgery (in which
some patients improve, whereas others die) depends
more on the effectiveness of volume unloading as a
result of the surgery, that is, the “reverse remodeling
viability” (3) of the compromised LV myocardium.
Strategies for risk stratiﬁcation by applyingcviability indexes beyond LV size and ejection
fraction may play a critical role in enabling
patients and attending physicians to under-
stand the risk, prognosis, and available re-
sources (i.e., guideline-directed medical
therapy [GDMT], transcatheter mitral valve
repair system, mitral surgery, ventricular
assistance device [VAD]/transplantation, or
palliative care). Most previous reports (4–9)
on mitral surgery for dilated poor LV func-
tion, however, have neither focused on
NICSMR (mostly ischemic etiology) nor re-
ﬂected the results of recent advancements,
such as cardiac resynchronization therapy
(CRT), which is a Class I recommendationwith a Level of Evidence: A (2) for NICSMR patients
with appropriate indications (10). As a result, patients
are offered CRT before mitral surgery or receive a CRT
system at the time of mitral surgery. The character-
istics and prognosis of these patients also remain
unclear.
Left ventricular torsion (LV-Tor), which originates
in the myocardial architecture and conduction sys-
tem, may be a sensitive indicator of cardiomyopathy
and disturbances of intra-LV conduction. LV-Tor may
therefore be considered a viability index, as sug-
gested by “force-dependent” LV strain (11). In
contrast, right ventricular pacing and biventricular
pacing generally result in decreases in LV-Tor (12); it
has therefore also been suggested that LV torsional
mechanics is not an essential component of LV
function in left bundle branch block (LBBB) or during
CRT (13).Therefore, we investigated whether pre-operative
LV-Tor and QRS width/CRT use can predict post-
operative survival and LV reverse remodeling in pa-
tients with NICSMR and can ultimately identify an
optimal clinical approach to identifying the appro-
priate treatment in patients with NICSMR.
METHODS
STUDY DESIGN. From September 2006 to August
2012, 50 consecutive patients with NICSMR who were
scheduled for mitral surgery at the Hayama Heart
Center, Kanagawa, Japan, were included in this
observational study, which was approved by the local
ethics committee. NICSMR stands for nonischemic,
chronic, severe secondary mitral regurgitation. The
term nonischemic in this study refers to idiopathic
cardiomyopathy, as deﬁned by the World Health
Organization/International Society and Federation of
Cardiology Task Force (14,15). All patients included
were in an advanced symptomatic state (New York
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195Heart Association functional class III or IV), had
already received the maximum GDMT for more than
6 months, had no prior surgical history, and provided
written informed consent before inclusion in the
study. The study ﬂow chart and group categorization
are shown in Figure 1. On the basis of the
pre-operative baseline LV-Tor proﬁle and QRS width
(<120 or $120 ms), we divided the 50 patients into
3 groups: the Preserved, Lost, and WideQRS/CRT
groups. The WideQRS/CRT group was subdivided into
the PrevCRT (patients who received CRT before the
mitral surgery) and PlusCRT (patients who were given
CRT at the time of the mitral surgery) groups. All
patients in the WideQRS/CRT group received CRT
after the mitral surgery. We followed the clin-
ical/survival status and echocardiographic variables
of the 50 patients for at least 2 years after the mitral
surgery.
SURGICAL PROCEDURES. Surgical correction of MR
was performed with preservation of the subvalvular
apparatus, which acts as a modulator of contractility
and LV-Tor (16). Mitral valve (MV) repair was per-
formed with annuloplasty (Carpentier-Edwards
Physio or Physio II Annuloplasty Ring [Edwards
Lifesciences, Irvine, California]; median ring size:
28 mm) with or without second chordal cutting
and/or adding artiﬁcial chordae tendineae. According
to the U.S. guidelines (2), MV repair was preferredFIGURE 1 Study Flow Chart and Group Categorization
CRT ¼ cardiac resynchronization therapy; echo ¼ echocardiography; LBB
nonischemic chronic severe mitral regurgitation; pts ¼ patients; Upgrad
ventricular pacer/implantable cardioverter-deﬁbrillator.over MV replacement if possible; replacement was
performed in 9 patients (18%) on the basis of the
surgeons’ intraoperative preference, and tricuspid
surgery (annuloplasty with or without edge-to-edge
repair) was performed in 29 patients (58%) who also
had severe functional tricuspid regurgitation or
tricuspid annulus dilation. For patients in the
PlusCRT subgroup, an epicardial LV lead was placed
intraoperatively and optimal CRT was performed
immediately after the surgery.
ECHOCARDIOGRAPHIC ANALYSIS. All 2-dimensional (2D)
echocardiographic measurements (including MR
quantiﬁcation according to the proximal isovelocity
surface area method with angle correction) fol-
lowed the recommendations of the American
Society of Echocardiography and American Heart
Association/American College of Cardiology (2,17).
Conventional 2D, Doppler, and speckle tracking
echocardiography (STE) were performed using
commercially available equipment and analyzed on
a workstation (Vivid7 or E9 with an M4S or M5S [1.5
to 4.3 MHz and 2.2 to 5.0 MHz] transducer and
EchoPAC, GE Healthcare, Horten, Norway) as previ-
ously reported (12,18–20). LV contractility/elastance
was determined with the end-systolic wall stress
and volume ratio (ESWS/ESVI) (21–24).
Deﬁnitions of “preserved” and “lost” LV torsion. Using the
systolic torsional proﬁles analyzed by 2D-STE, weB ¼ left bundle branch block; LV ¼ left ventricular; NICSMR ¼
e ¼ upgrading to cardiac resynchronization therapy from a right
FIGURE 2 Averaged LV Rotation/Torsion Proﬁle in the Preserved and Lost Groups
The LV rotation/torsion proﬁle curves were averaged across all patients in each group. Blue, light green, and dark green indicate apical, mid-,
and basal rotation, respectively. Purple indicates LV torsion. Time 0/100 indicates time of onset of QRS/AC. AC ¼ aortic valve closed;
AO ¼ aortic valve open; LV ¼ left ventricular.
FIGURE 3 Post-Operative Reverse Remodeling
The LV volume (A) and EF (B) were calculated with the area-length method. 1 week, 1 month, 6 months, 1 year, and 2 years indicate 1 week, 1
month, 6 months, 1 year, and 2 years after mitral surgery, respectively. The dotted line in the graphs indicates the number of remaining
survivors was less than one-half of the initial number of patients (i.e., more than one-half died at that time). *Signiﬁcantly different from
baseline (Pre). #Signiﬁcantly different from the prior study. D/L (C) ¼ ratio of left ventricular diameter and length; EF ¼ ejection fraction;
ESWS/ESVI (E) ¼ end-systolic wall-stress per indexed end-systolic volume (mm Hg/ml/m2); Mass (D) ¼ indexed LV mass (g/m2); MR ¼ mitral
regurgitation; Pre ¼ pre-operative baseline data.
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TABLE 1 Pre-Operative Variables
Whole Cohort
(n ¼ 50)
2 Years After Mitral Surgery
Survivors
(n ¼ 31)
Nonsurvivors
(n ¼ 19) p Value
Clinical indexes
Age, yrs 62  11 63  10 62  12 0.81
Female 15 (30) 11 (35) 4 (21) 0.35
Body surface area, m2 1.59  0.20 1.63 (1.47–1.77) 1.57 (1.43–1.66) 0.30
Body mass index, kg/m2 21  3 21  3 20  3 0.16
Atrial ﬁbrillation/ﬂutter 13 (26) 10 (32) 3 (16) 0.32
QRS width, ms 116 (98–136) 103 (96–135) 118 (100–152) 0.33
Previous CRT 6 (12) 1 (3) 5 (26) 0.024
NYHA functional class 3.6  0.5 3.5  0.5 3.7  0.5
III 20 (40) 17 (55) 13 (68) 0.39
IV 30 (60) 14 (45) 6 (32)
STS score 1.20 (0.95–2.14) 1.15 (0.91–1.82) 1.24 (0.99–3.01) 0.23
Echocardiographic indexes
LV end-diastolic
dimension/BSA, cm/m2
4.6  0.6 4.5 (4.1–5.0) 4.8 (4.3–4.9) 0.07
LV end-diastolic volume/BSA,
ml/m2
Biplane 132 (111–145) 124 (107–140) 142 (129–165) 0.005
Area-length 170  46 162  47 181  43 0.17
LV ejection fraction, %
Biplane 27  8 27  9 26  6 0.80
Area-length 24 (20–36) 27 (20–37) 23 (20–26) 0.18
LV shape, diameter/length 0.77  0.07 0.76  0.07 0.79  0.07 0.12
LV mass/BSA, g/m2 180  45 174  44 189  46 0.25
LV torsion,  4.6  6.0 6.1  4.7 2.0  7.3 0.018
Left atrial volume/BSA,
ml/m2
80 (55–131) 74 (54–105) 99 (75–136) 0.23
MR volume/BSA, ml/m2 31  8 31  8 31  7 0.90
Effective regurgitant oriﬁce
area of the MR, cm2
0.41 (0.31–0.50) 0.35 (0.31–0.49) 0.46 (0.34–0.54) 0.09
Values are mean  SD, n (%), or median (interquartile range). Society of Thoracic Surgeons score was calculated
on version 2.81. Values in bold indicate a signiﬁcant p value (p < 0.05).
BSA ¼ body surface area; CRT ¼ cardiac resynchronization therapy; LV ¼ left ventricular; MR ¼ mitral
regurgitation; NYHA ¼ New York Heart Association.
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197divided narrow QRS patients into 2 groups: the Pre-
served and Lost (LV-Tor) groups. Preserved was
deﬁned as a preserved normal systolic torsional pro-
ﬁle and positive net torsion (i.e., apical to basal
rotation) through the systole following reverse tor-
sion in the very early phase. Positive rotation or tor-
sion was indicated by a counterclockwise direction
when the LV was viewed from the apex. In most
cases, this condition was the result of positive apical
and negative basal rotation. Lost was deﬁned as a loss
of the normal systolic torsional proﬁle, which was
typically due to large negative apical rotation and
small basal negative rotation. As a result, the LV-Tor
proﬁles of the lost torsion patterns were negative
(persistent reverse net torsion) during systole
(Figure 2). All of the apical short-axis images were
assessed for the appropriateness of the scanned level
(Supplemental Table 1).
STATISTICAL ANALYSIS. The normality of the vari-
ables was assessed with the Kolmogorov-Smirnov
test. Continuous variables are expressed as the
mean  SD if normally distributed or by the median
(interquartile range) for variables with a skewed dis-
tribution. On the basis of the normality of the vari-
ables, the parametric or the nonparametric test was
chosen as appropriate. Categorical variables are
expressed as counts and percentages. The error bars
in the LV torsional proﬁles and Figure 3 are shown as
the mean  SE. Comparisons between survivors and
nonsurvivors were made using the Student t test or
the Mann-Whitney U test. Categorical variables were
analyzed using the chi-square test or Fisher exact test
(when the expected cell frequency was <5). The cat-
egorical variables were analyzed with residual anal-
ysis to identify the category responsible for a
chi-square statistic. Multiple comparisons were
made among the 3 groups using analysis of variance
or the Kruskal-Wallis test with Sheffé’s post-hoc
analysis. Kaplan-Meier curves were constructed to
show patients’ survival after the mitral surgery over
time. The index date was the date of the surgery. The
primary endpoints were analyzed until death (all
causes), the implantation of VAD, or the study
termination date. Survival among groups was
compared using the log-rank test. Changes in vari-
ables from baseline to follow-up were analyzed using
paired t tests or Wilcoxon matched-pairs analysis.
Statistical analysis was performed with the Statis-
tical Package for Windows (Excel Statistics 2012, So-
cial Survey Research Information Co., Ltd., Tokyo,
Japan) and R software version 3.0.3 (R Foundation
for Statistical Computing, Vienna, Austria). A 2-tailed
p value <0.05 was considered signiﬁcant.RESULTS
The study was terminated in September 2014. We
followed up with 42 patients (84%) at the Hayama
Heart Center; the other patients’ data were provided
by their primary attending physicians. The median
follow-up term was 2.5 years (interquartile range:
0.9 to 4.5 years).
PRE-OPERATIVE VARIABLES. The baseline pre-operative
variables of the entire cohort and the 2-year survi-
vors/nonsurvivors after mitral surgery are shown in
Table 1.
Pre-operative clinical status did not differ between
post-operative survivors and nonsurvivors except
when CRT had previously been used. The Society
of Thoracic Surgeons scores among the Preserved,
Lost, and WideQRS/CRT groups were also similar
CEN
Notom
(A and B
In the l
subdivid
Lost gro
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in general, a difference between the study groups
could not be found in the pre-operative variables)
(Supplemental Table 2).
Baseline LV size, shape, and mass tended to be
larger and more spherical in nonsurvivors; however,
there was no statistical difference except in the LV
volume estimated by the biplane disk summation.
The LV ejection fraction and MR severity were virtu-
ally identical among the groups; the LV torsion,
however, was higher in survivors.
POST-OPERATIVE SURVIVAL. During the study
period, there was no operative mortality; 19 patients
reached the primary endpoint: 12 died of congestive
heart failure, 1 received VAD implantation, 4 died
suddenly, and 2 died of noncardiac causes (1 from
pneumonia and 1 from infectious spondylitis). These
2 noncardiac deaths occurred in the Preserved group.
The Central Illustration shows the LV torsional
proﬁles and Kaplan-Meier curves for the endpoint
in the 3 categorized groups (panel A) and in the
subgroups of the WideQRS/CRT group (panel B).TRAL ILLUSTRATION Pre-Operative LV Torsional
i, Y. et al. J Am Coll Cardiol Basic Trans Science. 2016;1(4):193–202.
) The legends of upper graphs of LV torsional proﬁle are the same as in Figur
ower Kaplan-Meier graphs, the gray line indicates the survivor curve for all 5
ed 2 groups from the WideQRS/CRT group. In the lower Kaplan-Meier graphs
up curves in A for comparison (not all statistical analyses are shown, due toIn panel A, the end-systolic LV torsion was signiﬁ-
cantly higher in the Preserved group (8.2 3.6) than in
the Lost (1.4  5.0) and WideQRS/CRT (3.2  6.1)
groups, but there was no signiﬁcant difference
between the Lost and WideQRS/CRT groups. The log-
rank test indicated a signiﬁcant difference in the
2-year survival among the 3 groups (87%, 22%, and
50%; log-rank p< 0.0002). There was also a signiﬁcant
difference between the Preserved and WideQRS/CRT
groups (p < 0.007) but not between the WideQRS/CRT
and Lost groups (p ¼ 0.067, but statistical power 0.39).
In panel B, although the LV torsional proﬁle was not
signiﬁcantly different between the subgroups (end-
systolic torsion: 2.7  5.4 in PlusCRT and 4.5  6.4
in PrevCRT; p ¼ 0.45), the PrevCRT group showed
signiﬁcantly worse 2-year survival than the PlusCRT
group (17% vs. 67%; log-rank p < 0.006).
Congestive heart failure hospitalization was very
frequent in patients in the Lost group (67%) but
relatively infrequent in the Preserved group (9%).
Moderate or higher MR recurrence after mitral repair
was observed in 2 patients in the Preserved group andProﬁle and Post-Operative Survival
e 1. (A) LV torsional proﬁles and Kaplan-Meier curves in the 3 groups.
0 patients. (B) LV torsional proﬁles and Kaplan-Meier curves in the
, the thin black and red lines are superimposed on the Preserved and
a similar trend and a small number).
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1991 patient each in the Lost and WideQRS/CRT groups
during follow-up; this was treated medically in all
cases.
POST-OPERATIVE REVERSE REMODELING. Figure 3
shows the degree and course of the LV reverse
remodeling in each of the 3 groups.
To better understand the reverse remodeling after
mitral surgery, we also analyzed the comparative data
of age- and sex-matched 18 normal subjects and 12
patients with primary MR.
F igure 3A. At 1 week and 1 month, decreased LV size
as a result of volume unloading with mitral surgery
was observed in all groups except for the Lost group.
After 1 to 6 months, in the Preserved group, the LV
end-diastolic volume (EDV) gradually decreased,
whereas the LV end-systolic volume slowly and
signiﬁcantly decreased after 2 years compared with
the baseline (19  39% reduction from baseline;
p ¼ 0.027), but it remained high (112  47 ml/m2 to
89  48 ml/m2). The LVEDV in the primary MR group
returned to a normal level sooner than in the other
groups. No signiﬁcant LV volume reduction was
observed in the WideQRS/CRT or Lost groups after 2
years. Even the PlusCRT subgroup of the WideQRS/
CRT group did not manifest signiﬁcant reverse
remodeling; the end-systolic volume/body surface
area values were baseline: 141  51 ml/m2; 1 year:
152  41 ml/m2 (p ¼ 0.09); and 2 years: 136  36 ml/m2
(p ¼ 0.32 vs. baseline).
F igure 3B. LV function tended to show a mild tran-
sient decrease from 1 week to 6 months after surgery
in all groups, and thereafter returned to a normal
level in the primary MR group and to the baseline
level in the Preserved group at 6 months. The Pre-
served group showed delayed and insigniﬁcant
improvement over the course of 2 years, whereas the
other groups did not.
F igure 3C . The LV shape gradually became more
elliptical toward normal only in the Preserved group
(but still spherical at 2 years), whereas the shape
rapidly normalized in primary MR.
F igure 3D. Transient LV mass increment at 1 week
(suggesting the effect of cardioplegia) was observed
in all groups except for the Lost group. The LV mass
returned to the baseline level at 1 month and was
stable thereafter, except in the primary MR group.
The primary MR group continued to exhibit regres-
sion of the LV mass to the normal level over 2 years,
whereas the Preserved group did not show similar
regression.
F igure 3E. The LV contractility/elastance of the
primary MR group was normalized over a period of
2 years, but the NICSMR groups did not increase more
than the baseline.It should be mentioned that most trends of reverse
remodeling in the WideQRS/CRT group were not
found to be dissimilar to those in PrevCRT and/or
PlusCRT patients. One reason for this ﬁnding is that
most patients in the PrevCRT subgroup died within
1 year.
DISCUSSION
The main ﬁndings of the current study are as follows:
1. For patients with NICSMR and a narrow QRS width,
preserved LV-Tor may be a better predictor of post-
mitral surgery survival; conversely, lost LV-Tor
may imply a poor post-surgical outcome. Impor-
tantly, pre-operative LV size, EF, and geometric
shape were not signiﬁcantly different between
2-year survivors and nonsurvivors in our cohort.
2. The post-surgical survival results were intermedi-
ate in patients with a wide (LBBB pattern) QRS. This
group was divided into 2 subgroups for discussion
because patients who had previously undergone
CRT had signiﬁcantly poorer survival, and those
with newly performed CRT at the time of surgery
had relatively better survival after mitral surgery,
although the 2 subgroups had a similar LV-Tor.
3. Therefore, lost LV-Tor and previously adminis-
tered CRT appeared to be markers of poor survival
after mitral surgery in patients with NICSMR.
4. Reverse remodeling was observed only in the
preserved LV-Tor group. Hence, lost LV-Tor and
wide QRS (even in the PlusCRT subgroup) were
markers of no reverse remodeling viability.
In short, as a clinical scenario, patients with
NICSMRwho have lost LV-Tor and a narrow QRS width
or previous CRT implementation appeared to beneﬁt
less from mitral surgery; however, for patients with
preserved LV-Tor and a narrow QRS, mitral surgery
seemed to be an acceptable option. Thus, the assess-
ment of LV-Tor may be useful for the prediction of
post-mitral surgery outcomes in patients with a nar-
row QRS but not in those with a wide QRS, including
patients with previous CRT implementation.
Hereafter, we discuss the pathophysiological
rationale and clinical relevance of the current study.
LV-TOR AND REVERSE REMODELING: RECOVERY,
REMISSION, OR PLASTIC. Although patients in the
Preserved group showed a signiﬁcant reverse
“chamber” remodeling after MR elimination, the LV
mass did not regress (keeping the initial mass vol-
ume) over 2 years; consequently, it re-remodeled
toward concentric LV geometry. This re-remodeling
appeared to lead to a decrease in wall stress without
an increase in ESWS/ESVI during the 2 years of
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remodeling course of primary MR, which showed a
decrease in both chamber and mass and could truly be
called “recovery” (improvement of the myocytes’
contractility). The Preserved group, therefore,
appeared to be in “remission” (maintaining initial
contractility) rather than recovery (25). To normalize
the LV performance, with weak and compromised
myocardium/myocytes this “re-remodeling” would
be required. Thus, patients with preserved torsion
would receive minimal (survival) beneﬁt from vol-
ume unloading treatment.
In addition, the “plastic region” (25) might be
characterized in the Lost group by no signiﬁcant LV-
Tor (hence, no chamber elliptization during systole)
(Supplemental Table 3), poor post-surgical survival,
and no reverse remodeling, in which the LV myocar-
dium was irreversibly damaged and did not have the
ability to respond to the volume-unloading treat-
ment. The LV in the Lost group also appeared to be
entirely pre-load dependent; it did not decrease in
LVEDV after surgery (instead exhibiting re-dilation).
The LV in the Lost group may have sustained irre-
versible myocellular damage in the plastic or “creep”
region (irreversible “slippage” between myoﬁbrils
[26]) and did not achieve “remission” after mitral
surgery. Thus, the lost LV-Tor proﬁle might be a sign
of requiring a ventricular assistance device.
Together, our results suggest the hypothesis that
LV torsion may indicate the contractility/elastance
(which enables reverse remodeling) of the LV
compromised myocardium in NICSMR patients. LV-
Tor was modestly but signiﬁcantly correlated with
ESWS/ESVI in our cohort (r2 ¼ 0.17; p ¼ 0.003).
CRT IN NICSMR. Pathophys io logy. It has been sug-
gested that LV torsional mechanics require a normal
synchrony (normal and rapid LV activation sequence)
and that LV rotation mechanics may not be an
essential component of LV function in cases of LV
dyssynchrony and epicardially paced resynchroniza-
tion (13). In other words, LV in LBBB and CRT con-
tracts without torsional mechanics, which is a
physiological advantage on the basis of the architec-
ture. This contraction may be why the WideQRS/CRT
group showed unusual LV torsional proﬁles, which
required the creation of another group.
The mechanical discoordination indexes CURE
(circumferential uniformity ratio estimate) (27) and
ISF (internal stretch fraction) (28), calculated by the
numerical data derived from 2D-STE, showed border-
line discoordination values in both the PrevCRT and
PlusCRT subgroups (Supplemental Table 4). Thus, the
PrevCRT subgroup maintained some degree of dis-
coordination, whereas the PlusCRT group did notexhibit severe discoordination. This difference may
explain why volume unloading (mitral surgery) and
resynchronization would not be effective for promot-
ing reverse remodeling in both subgroups. Addition-
ally, favored reverse remodeling might be prevented
by surgical factors such as systemic inﬂammatory
response or myocardial oxidative stress/free radical
injury with cardiopulmonary bypass, cardioplegia,
and complete cardiac arrest. Hence, implementation
of CRT before mitral surgery on the basis of appro-
priate indications would be needed, as suggested in
the guidelines.
CORRECTION OF UNIMPROVED MR AFTER CRT IN NICSMR.
Although the effect of CRT on secondary MR was
clear, MR persists in 30% to 40% of CRT patients
(29–31) in the real world. The natural history of CRT
nonresponders (nonfunctional MR improvers) is poor,
with a reported 2-year mortality of 50% (29,30) and
3-year mortality up to 70% (31). In the present study,
surgical correction of unimproved MR after CRT in
NICSMR was unsuccessful. A recent report on the
MitraClip (Abbott Vascular, Santa Clara, California),
however, has demonstrated excellent results in such
patients and “it emphasized the need to stratify early
after CRT those patients who may either develop FMR
or in whom FMR is unlikely to change (decrease)
as well as need to consider additional therapeutic
options such as (mitral) surgery or MitraClip treat-
ment” (32).
STUDY LIMITATIONS AND FUTURE DIRECTIONS. We
should address several limitations of this observa-
tional study, which was conducted at a single center.
Although consecutive patients were selected from
a real-world clinic, the patient population was small
and the follow-up term was short. A larger number of
WideQRS/CRT group patients, speciﬁcally, should be
included in the future to obtain more robust
conclusions.
The mean effective regurgitant oriﬁce area/
regurgitant volume/regurgitant fraction was
0.41 cm2/48 ml/60% in the entire cohort. Because
the current Western guidelines (2,33) indicate a
value >0.2 cm2/>30 ml/>50% as severe, the symp-
toms of many patients observed in this study might
have been too severe (or too late) at the time of
referral to surgery. Unexpectedly, LV size, EF, and
shape were not post-operative discriminators in this
study. No assumption method using robust high-
resolution 3-dimensional imaging (echocardiography
or CMR) modalities can accurately assess the MR and
LV volume (34–36).
Although it was beyond the scope of the current
study, it is of note that nonsurvivors in our
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: Preservation of
the LV systolic torsional proﬁle may be a helpful predictor for
post-mitral surgery survival and reverse remodeling in patients
with NICSMR who have a narrow QRS. Patients who received CRT
prior to mitral surgery had poor post-surgery survival, whereas
those who received CRT at the time of mitral surgery had better
survival but no reverse remodeling.
TRANSLATIONAL OUTLOOK: Further randomized controlled
trials are needed to determine whether clinical stratiﬁcation with
an LV torsional proﬁle and QRS width/CRT use is associated with
better, longer-term clinical outcomes after mitral surgery (and
other resources) in patients with NICSMR.
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201cohort tended to have a larger right ventricle
(possibly related to more required tricuspid surgery
and higher levels of brain natriuretic peptide)
(Supplemental Table 5). Right ventricular size was
weakly inversely related to LV-Tor (r2 ¼ 0.10; p ¼
0.026). A multivariate Cox analysis in an appropri-
ately sized randomized study might be able to
determine the signiﬁcance and independence of
those indexes with sufﬁcient statistical power. In the
current study, the small sample precluded the ability
to adjust for potential confounding factors when
analyzing survival.
We did not include a medically treated control
group. A randomized prospective trial of mitral sur-
gery and GDMT in far-advanced LV dysfunction and
heart failure has not been explored to date. It may be
appropriate to determine the best clinical approach
for NICSMR patients with the results of an analysis of
quality-adjusted life-years and incremental cost-
effectiveness in such trials. VAD as a destination
therapy generally leads to 70% survival at 2 years
(37), which may serve as a measure of survival suc-
cess for other resources. The ongoing COAPT study
(NCT01626079) involving patients with NICSMR with
and without CRT will shed light on this issue.
Finally, to treat primary myopathy, regenerative
therapy to attain myocardial “recovery” would
potentially facilitate therapeutic responses in
NICSMR patients.
CONCLUSIONS
In patients with NICSMR, the LV torsional proﬁle
assessed with 2D-STE discriminated post-mitral sur-
gery outcomes in patients with a narrow QRS but
not in those with a wide QRS, and previouslyimplemented CRT appeared to be a marker of poor
post-surgical survival.
The National Institutes of Health Fact Sheet (38)
states that among adults, the 5-year relative survival
rate for all cancers combined is now approximately
68%, whereas it was 50% in our entire cohort.
Determining the safest and most effective manage-
ment for NICSMR patients is the goal. The ﬁndings of
this study may help to resolve this clinical dilemma
and identify appropriate candidates for mitral surgery
in patients with NICSMR.
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